The young militant told Xinhua that rumor said 1.9 million fraudulent polling cards have been made in favor of IBK, that's why the delegate of Cisse felt obligatory to check the photo in the cards to verify that it is the same face of the holder of the card.
With agitation created by this incident, President of the Commission of the Economic Community of Western African States (ECOWAS) Kadre Desire Ouedraogo, had been called on for an arbitrage by the angry Protestants.
ECOWAS has deployed 150 observers headed by former president of Ghana, John Kufuor, to oversee this election.
IBK, the 68-year-old leading candidate, cast his vote at about 10: 40 at the center of Sebeninkoro Ecole AB, in the 4th commune of Bamako, where a deployment of security measures is visible outside as well as inside.
Shortly after the voting, IBK told press at his residence that, if he is elected, he will form a government which will "make sure that our whole country gets back onto the base of unity".
IBK has garnered 39.97 percent of the votes in the first round held on July 28, largely ahead of his rival Soumaila Cisse, who got 19.70 percent. He had this favorable position consolidated following the announcement of results of the first round, as 20 of the 25 eliminated candidates of the first round chose to support his candidature in the second round.
For the outgoing president of transition, the conduct of Sunday's is "satisfying". "The voters have voted freely, in mass," said Traore when answering a question by Xinhua.
"I think we can say that the transition has been a success. Now we will enter a new phase, the phase of reconstruction of the Malian State and the unification of the Malien people," he said.
2/2 首页 上一页 1 2
- 欧美文化:Feature: UK takes big step toward normal life with caution urged
- 欧美文化:DRC president hails mining, infrastructure cooperation with China
- 欧美文化:Israel-Gaza violent tension continues for 5th day with no sign of cease-fire
- 欧美文化:Global energy consumption increases with easing COVID-19 restrictions: EIA
- 欧美文化:EU's contract with AstraZeneca "valid until last doses delivered": spokesperson